EMA workshop: Non-clinical data for regulatory decision-making on the efficacy of medical countermeasures, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 November 2025, 09:00 (CET) to 25 November 2025, 16:00 (CET)

Quarterly System Demo - Q4 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 December 2025, 09:30 (CET) to 16 December 2025, 12:35 (CET)

Union Product Database: release notes

Release notes - production release version 1.7.2544 - 5 December 2025 - Veterinary Medicinal Products Regulation: Union Product Database

Human medicines European public assessment report (EPAR): Ebglyss, lebrikizumab, Date of authorisation: 16/11/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Lyfnua, gefapixant, Date of authorisation: 15/09/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Eucreas, vildagliptin,metformin, Date of authorisation: 14/11/2007, Revision: 27, Status: Authorised

EMA/PE/0000224486

EMA/PE/0000221803

Product Management Service (PMS) roadmap